San Diego, CA, United States of America

Samuel Sperry


 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2005-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Samuel Sperry

Introduction

Samuel Sperry is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that address critical health issues. With a total of 2 patents, his work focuses on innovative solutions for metabolic disorders, inflammatory diseases, and cancer.

Latest Patents

Sperry's latest patents involve linked biaryl compounds. These compounds, compositions, and methods are designed to be useful in treating metabolic disorders, inflammatory diseases, and cancer. Specifically, his inventions provide compounds that modulate the expression and/or function of proteins involved in lipid metabolism, inflammation, and cell proliferation. The subject compounds are linked biaryl compounds, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Samuel Sperry has worked with notable companies, including Japan Tobacco Inc. and Tularik Limited. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in his field.

Collaborations

Sperry has collaborated with esteemed colleagues such as Hiroyuki Abe and Jonathan B Houze. These partnerships have further enriched his work and expanded the impact of his inventions.

Conclusion

Samuel Sperry's innovative contributions to biochemistry and his focus on linked biaryl compounds highlight his dedication to addressing significant health challenges. His work continues to inspire advancements in medical treatments and showcases the importance of innovation in science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…